Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6470133

COCCOc1ccc2nc(Nc3nc(O)c4cc([N+](=O)[O-])cc(C)c4n3)nc(C)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.35
LMNA P02545 4/20 0.35
MITF O75030 2/20 0.35
MEN1 O00255 5/20 0.35
MAPT P10636 6/20 0.35
PIN1 Q13526 5/20 0.35
KDM4E B2RXH2 4/20 0.35
GAA P10253 2/20 0.35
STAT3 P40763 1/20 0.35
ALDH1A1 P00352 3/20 0.34
AURKA O14965 1/20 0.34
PSMD14 O00487 1/20 0.34
APAF1 O14727 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
PTK2B Q14289 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TDP2 O95551 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470135 0.88 KMT2A (0.34) KMT2ALMNAMITFMEN1MAPT
Trifluoroacetic Acid SCHEMBL6469682 0.87 KDM4E (0.39) KMT2ALMNAMITFMEN1MAPT
SCHEMBL6467440 0.84 MEN1 (0.46) KMT2ALMNAMEN1MAPTPIN1
Trifluoroacetic Acid SCHEMBL6466107 0.83 ABCG2 (0.41) KMT2ALMNAMAPTALDH1A1
Trifluoroacetic Acid SCHEMBL6470467 0.81 ADORA2A (0.40) KMT2ALMNAMITFMEN1MAPT
Trifluoroacetic Acid SCHEMBL6467088 0.81 TYMS (0.35) KMT2ALMNAMEN1MAPTALDH1A1
Trifluoroacetic Acid SCHEMBL6466263 0.81 MAPT (0.40) KMT2ALMNAMITFMEN1MAPT
Trifluoroacetic Acid SCHEMBL6470592 0.79 POLB (0.38) KMT2AMEN1MAPTGAAALDH1A1
Trifluoroacetic Acid SCHEMBL6470554 0.77 KDM4E (0.46) KMT2ALMNAMEN1MAPTKDM4E
Trifluoroacetic Acid SCHEMBL6466210 0.77 SRC (0.39) KMT2ALMNAMITFMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885LMNA 1700/4885MITF 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.